作者：
Aki,Sato [1]
;
Masayuki,Kobayashi [2]
;
Nozomi,Yusa [3]
;
Miho,Ogawa [4]
;
Eigo,Shimizu [5]
;
Toyotaka,Kawamata [1]
;
Kazuaki,Yokoyama [1]
;
Yasunori,Ota [6]
;
Tatsuo,Ichinohe [7]
;
Hitoshi,Ohno [8]
;
Yasuo,Mori [9]
;
Emiko,Sakaida [10]
;
Tadakazu,Kondo [11]
;
Seiya,Imoto [5]
;
Yasuhito,Nannya [1]
;
Kinuko,Mitani [4]
;
Arinobu,Tojo [12]
作者单位：
Department of Hematology and Oncology, Institute of Medical Science Research Hospital, University of Tokyo, Tokyo, Japan.
[1]
Department of Hematology, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan.
[2]
Department of Applied Genomics, Institute of Medical Science Research Hospital, University of Tokyo, Tokyo, Japan.
[3]
Division of Hematopoietic Disease Control, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
[4]
Division of Health Medical Intelligence, Human Genome Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
[5]
Department of Diagnostic Pathology, Institute of Medical Science Research Hospital, University of Tokyo, Tokyo, Japan.
[6]
Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
[7]
Department of Hematology, Tenri Hospital, Nara, Japan.
[8]
Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
[9]
Department of Hematology, Chiba University Hospital, Chiba, Japan.
[10]
Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
[11]
Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan.
[12]
Institute of Innovation Advancement, Tokyo Medical and Dental University, Tokyo, Japan.
[13]
DOI
10.1111/cas.15879
PMID
37364599
发布时间
2023-09-06
换一批
换一批
